Journal article
Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated With Tisagenlecleucel in the Real-World Setting
Authors
Landsburg DJ; Heim M; Moskop A; Foley SR; Hill BT; Schofield G; Jacobson CA; Jaglowski S; Locke FL; Ram R
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 24, ,
Publisher
Elsevier
Publication Date
September 1, 2024
DOI
10.1016/s2152-2650(24)00807-3
ISSN
2152-2650